Cargando…
Antidepressants and type 2 diabetes: highways to knowns and unknowns
Type 2 diabetes (T2D) is a metabolic disease caused by the development of insulin resistance (IR), relative insulin deficiency, and hyperglycemia. Hyperglycemia-induced neurochemical dysregulation activates the progression of depression in T2D patients. Therefore, management of depression by antidep...
Autores principales: | Alruwaili, Nahi Sabih, Al-Kuraishy, Hayder M., Al-Gareeb, Ali I., Albuhadily, Ali K., Ragab, Amany E., Alenazi, Ahmad Awad, Alexiou, Athanasios, Papadakis, Marios, Batiha, Gaber El-Saber |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470155/ https://www.ncbi.nlm.nih.gov/pubmed/37653558 http://dx.doi.org/10.1186/s13098-023-01149-z |
Ejemplares similares
-
Sildenafil and depression: True or false prophecy
por: Al‐Kuraishy, Hayder M., et al.
Publicado: (2023) -
The potential link between Covid‐19 and multiple myeloma: A new saga
por: Al‐Kuraishy, Hayder M., et al.
Publicado: (2022) -
Monkeypox epidemic at the door: should we remain idly by or prepare strongly?
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2023) -
Heparanase is the possible link between monkeypox and Covid-19: robust candidature in the mystic and present perspective
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2023) -
The potential role of scavenger receptor B type I (SR‐BI) in SARS‐CoV‐2 infection
por: Alkazmi, Luay, et al.
Publicado: (2023)